NEUROCRINE BIOSCIENCES INC (NBIX) Form 10-K Annual Reports
NEUROCRINE BIOSCIENCES INC (NBIX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NBIX
CIK: 914475
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerTim Holl
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-15 | — | SCHEDULE 13G/A Filing | 0000019617-26-000371 | View SEC Doc Filr Page |
| 3 | 2026-10-07 | 2026-09-28 | FORM 3 | 0001727606-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0000914475-26-000045 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001894425-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001504783-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001818524-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001201096-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001567160-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001965808-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001776977-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001909817-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001643653-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001724097-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001950047-26-009441 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001950047-26-009412 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-09 | FORM 4 | 0001643653-26-000016 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001950047-26-009240 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001079462-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | FORM 4 | 0001894425-26-000018 | View SEC Doc Filr Page |
| S-8 | 2026-07-31 | — | S-8 | 0000914475-26-000040 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-31 | 2026-05-14 | 8-K/A | 0001193125-26-328470 | View SEC Doc Filr Page |
| 10-Q | 2026-07-31 | 2026-06-30 | 10-Q | 0000914475-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001533568-26-000012 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0000914475-26-000035 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0000019617-26-000313 | View SEC Doc Filr Page |